Headlines

Key Takeaways From Inari Medical Analyst Ratings

Latest Ratings for NARI

DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsOverweight Feb 2022SVB LeerinkMaintainsOutperform Nov 2021SVB LeerinkMaintainsOutperform

View More Analyst Ratings for NARI

View the Latest Analyst Ratings

Leave a Reply

Your email address will not be published. Required fields are marked *